Race Oncology Ltd

RAONF:OTCPK
RT Quote | Exchange | USD
Last | EST
UNCH (UNCH)
52 week range
0.00 - 0.00

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close-
  • 52 Week High0.00
  • 52 Week High Date-
  • 52 Week Low0.00
  • 52 Week Low Date-
  • Market Cap156.67M
  • Shares Out116.45M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Race Oncology Ltd News

There is no recent news for this security.

Latest RAONF News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Race Oncology Limited, formerly Coronado Resources Limited, is an Australia-based specialty pharmaceutical company whose business model is to pursue and bring to market later stage assets, principally in the cancer field. The Company's Bisantrene drug is a chemotherapy drug, which is related to the anthracyclines, a class of drugs used as the first line of treatment for acute myeloid leukemia (AML) and other cancers. Its Bisantrene drug reduces cardiac toxicity compared to...
John Cullity
Non-Executive Chairman
Phillip Lynch
Chief Executive Officer
Samar Al-Behaisi
Vice President
Address
L 40 140 William Street
Melbourne, VIC
3000
Australia